Q3 2019 AngioDynamics Inc Earnings Call
שיחת ועידה AngioDynamics Inc
AngioDynamics Inc Conference call or earnings call will be held on 02/04/2019 via an 800 number (toll-free). During the earnings conference call's session AngioDynamics Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact AngioDynamics Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
AngioDynamics, Inc. (together with its subsidiaries, "AngioDynamics," the "Company," "we," "our" or "us") designs, manufactures and sells a wide range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Our devices are generally used in minimally invasive, image-guided procedures. History AngioDynamics was founded in 1988 and we completed our initial public offering in 2004, raising net proceeds of approximately $21.7 million at an offering price of $11.00 per share. In 2006 we completed a follow-on offering, raising net proceeds of approximately $61.9 million at a public offering price of $24.07 per share. Products Our product offerings fall within three product groupings: Peripheral Vascular, Vascular Access and Oncology/Surgery.קרא עוד שיחת ועידה